Perioperative Three-dimensional Echocardiography in Cardioanesthesia.
1 other identifier
observational
2,000
1 country
1
Brief Summary
The aim of this study is to investigate the significance of intraoperative echocardiography on the surgical course and association with patient outcome. Of particular interest is the three-dimensional assessment of cardiac and valvular function. The patient course from surgery to the time of hospital discharge will be followed up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2020
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2020
CompletedFirst Submitted
Initial submission to the registry
September 23, 2021
CompletedFirst Posted
Study publicly available on registry
January 13, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2025
CompletedJanuary 13, 2022
September 1, 2021
5.5 years
September 23, 2021
January 11, 2022
Conditions
Outcome Measures
Primary Outcomes (2)
In Hospital Mortality
up to 90 days
1-year Mortality
1 year
Secondary Outcomes (3)
ICU Length of Stay
up to 90 days
Days on Mechanical Ventilation
up to 90 days
Days with Circulatory Support
up to 45 days
Interventions
No intervention, just observation is performed.
Eligibility Criteria
Mixed population of adult patients undergoing cardiac surgery.
You may qualify if:
- Cardiac surgery or surgery on the vessels near the heart
You may not qualify if:
- Pregnant patients
- Unfeasibility of intraoperative echocardiography in contraindications to transesophageal echocardiography: esophageal carcinoma, varices, diverticula, strictures, acute esophagitis, previous esophageal or gastric bleeding, symptomatic hiatal hernia.
- No written consent obtainable.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universitätsklinikum Tübingen
Tübingen, Germany
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 2 Months
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 23, 2021
First Posted
January 13, 2022
Study Start
June 1, 2020
Primary Completion
December 1, 2025
Study Completion
December 1, 2025
Last Updated
January 13, 2022
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share